SNX20

ANTIBODY polyclonal manufacturer Cat# H00124460-B01P<br />Produced by Abnova immunogen = SLIC1 (aa1-129) full-length human protein liquid, no preservative, protein A purified SNX20- sorting nexin 20 Protein Trafficking Novus Biologicals Mouse Human SNX20 htt

SNX24

ANTIBODY polyclonal manufacturer Cat# H00028966-B01P<br />Produced by Abnova immunogen = SNX24 (NP_054754, aa1-169) full-length human protein liquid, no preservative, protein A purified SNX24- sorting nexin 24 Protein Trafficking Novus Biologicals Mouse Huma

SNX33

ANTIBODY polyclonal manufacturer Cat# H00257364-B01P<br />produced by Abnova immunogen = SH3PX3 (NP_695003.1, aa1-574 a.a) full-length human protein liquid, PBS, no preservative, protein A purified SNX33 (SH3PX3- SH3 and PX domain containing 3) Protein Traff

SNX19

ANTIBODY polyclonal manufacturer Cat# H00399979-B01<br />Produced by Abnova immunogen = SNX19 (AAH31620.1, aa1- 803) full-length human protein liquid, whole antiserum, no preservative SNX19 Protein Trafficking Novus Biologicals Mouse Human SNX19 http://alzfo

SNX24

ANTIBODY polyclonal manufacturer Cat# H00028966-B01<br />Produced by Abnova immunogen = SNX24 (NP_054754, aa1-169) full-length human protein liquid, whole antiserum, no preservative SNX24- sorting nexin 24 Protein Trafficking Novus Biologicals Mouse Human SN

Prvo Ime Drugo

�
United States

Chirilescu Marinela

Radauti, Romania

Lon S. Schneider on Phoenix: Making Trials Work for Patient, Sponsor, Regulator

COMMENT Suppose you have a registry or cohort of volunteers on whom you are gathering longitudinal data and can hence characterize their recent past history, and suppose you do so with ratings that are used in prevention trials. Then you have a cohort that you ca

PAPER Hageman J, Rujano MA, van Waarde MA, Kakkar V, Dirks RP, Govorukhina N, Oosterveld-Hut HM, Lubsen NH, Kampinga HH

A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.

Mol Cell. 2010 Feb 12;37(3):355-69. PubMed: 20159555

PAPER Jäderstad J, Jäderstad LM, Li J, Chintawar S, Salto C, Pandolfo M, Ourednik V, Teng YD, Sidman RL, Arenas E, Snyder EY, Herlenius E

Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host.

Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5184-9. PubMed: 20147621

PAPER Bush AI

Kalzium ist nicht alles.

Neuron. 2010 Jan 28;65(2):143-4. PubMed: 20152120

PAPER Slutsky I, Abumaria N, Wu LJ, Huang C, Zhang L, Li B, Zhao X, Govindarajan A, Zhao MG, Zhuo M, Tonegawa S, Liu G

Enhancement of learning and memory by elevating brain magnesium.

Neuron. 2010 Jan 28;65(2):165-77. PubMed: 20152124

PAPER Levine MS, Cepeda C, André VM

Location, location, location: contrasting roles of synaptic and extrasynaptic NMDA receptors in Huntington's disease.

Neuron. 2010 Jan 28;65(2):145-7. PubMed: 20152121

Fu-De Huang on Abnormal Mitochondrial Dynamics—Early Event in AD, PD?

COMMENT We thank all the commentators on our paper, "Expression of beta amyloid induced age-dependent presynaptic and axonal changes in Drosophila." Our examination, through genetic manipulation, of the role of critical mitochondria fission and fusion g

Alzheimer’s Prevention Initiative/DIAN Joint Industry Advisory Meeting

CONFERENCE COVERAGE SERIES Phoenix: Vision of Shared Prevention Trials Lures Pharma to Table Phoenix: Can Alzheimer’s Prevention Initiative Break a Catch-22? Phoenix: Trials in Colombia and the U.S. for Those at Highest Risk? Phoenix: For Shared Prevention Trials, Devil Is in the D